ENTRY       D10889                      Drug
NAME        Momelotinib hydrochloride hydrate (JAN);
            Momelotinib dihydrochloride monohydrate;
            Ojjaara (TN)
PRODUCT     OJJAARA (GlaxoSmithKline LLC)
FORMULA     C23H22N6O2. 2HCl. H2O
EXACT_MASS  504.1443
MOL_WEIGHT  505.3969
CLASS       Anti-inflammatory
             DG01985  Disease modifying anti-rheumatic drug (DMARD)
              DG02020  JAK inhibitor
            Metabolizing enzyme substrate
             DG01892  CYP1A2 substrate
             DG02918  CYP2C8 substrate
             DG01642  CYP2C9 substrate
             DG01639  CYP2C19 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Chemical structure group: DG01366
            Product (DG01366): D10889<US>
EFFICACY    Antineoplastic, Janus kinase (JAK) inhibitor
  DISEASE   Myelofibrosis [DS:H01605]
TARGET      JAK1 [HSA:3716] [KO:K11217]
            JAK2 [HSA:3717] [KO:K04447]
            JAK2* [HSA_VAR:3717v1] [HSA:3717] [KO:K04447]
            ACVR1 (ALK2) [HSA:90] [KO:K04675]
  PATHWAY   hsa04060(90)  Cytokine-cytokine receptor interaction
            hsa04550(3716+3717+3717+90)  Signaling pathways regulating pluripotency of stem cells
            hsa04630(3716+3717+3717)  JAK-STAT signaling pathway
METABOLISM  Enzyme: CYP3A4 [HSA:1576], CYP2C8 [HSA:1558], CYP2C9 [HSA:1559], CYP2C19 [HSA:1557], CYP1A2 [HSA:1544]
INTERACTION  
BRITE       Drug groups [BR:br08330]
             Anti-inflammatory
              DG01985  Disease modifying anti-rheumatic drug (DMARD)
               DG02020  JAK inhibitor
                DG01366  Momelotinib
                 D10889  Momelotinib hydrochloride hydrate
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG01366  Momelotinib
                D10889  Momelotinib hydrochloride hydrate
              DG02918  CYP2C8 substrate
               DG01366  Momelotinib
                D10889  Momelotinib hydrochloride hydrate
              DG01642  CYP2C9 substrate
               DG01366  Momelotinib
                D10889  Momelotinib hydrochloride hydrate
              DG01639  CYP2C19 substrate
               DG01366  Momelotinib
                D10889  Momelotinib hydrochloride hydrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG01366  Momelotinib
                 D10889  Momelotinib hydrochloride hydrate
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor serine/threonine kinases (RSTK)
               TGFBR1 family
                ACVR1 (ALK2)
                 D10889  Momelotinib hydrochloride hydrate (JAN) &lt;US&gt;
              Non-receptor tyrosine kinases
               JAK family
                JAK1
                 D10889  Momelotinib hydrochloride hydrate (JAN) &lt;US&gt;
                JAK2
                 D10889  Momelotinib hydrochloride hydrate (JAN) &lt;US&gt;
                JAK2* [HSA_VAR:3717v1]
                 D10889  Momelotinib hydrochloride hydrate (JAN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10889
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10889
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D10889
            Pharmacogenomic biomarkers [br08341.html]
             Somatic variations in targeted cancer therapies
              D10889
            Drug groups [BR:br08330]
             Anti-inflammatory
              DG01985  Disease modifying anti-rheumatic drug (DMARD)
               DG02020  JAK inhibitor
                DG01366  Momelotinib
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG01366  Momelotinib
              DG02918  CYP2C8 substrate
               DG01366  Momelotinib
              DG01642  CYP2C9 substrate
               DG01366  Momelotinib
              DG01639  CYP2C19 substrate
               DG01366  Momelotinib
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG01366  Momelotinib
DBLINKS     PubChem: 336445207
ATOM        34
            1   C1x C     8.3300  -18.3400
            2   O2x O     8.3300  -19.7400
            3   C1x C     9.5900  -20.4400
            4   C1x C    10.7800  -19.7400
            5   N1y N    10.7800  -18.3400
            6   C1x C     9.5900  -17.5700
            7   C8y C    12.0400  -17.5700
            8   C8x C    13.2300  -18.2700
            9   C8x C    14.4200  -17.5700
            10  C8y C    14.4200  -16.1700
            11  C8x C    13.2300  -15.4700
            12  C8x C    12.0400  -16.1700
            13  N1b N    15.6800  -15.4700
            14  C8y C    16.8700  -16.1700
            15  N5x N    16.8700  -17.5700
            16  C8x C    18.0600  -18.2700
            17  C8x C    19.3200  -17.5700
            18  C8y C    19.3200  -16.1700
            19  N5x N    18.0600  -15.4700
            20  C8y C    20.5100  -15.4700
            21  C8x C    21.7000  -16.1700
            22  C8x C    22.8900  -15.4700
            23  C8y C    22.8900  -14.0700
            24  C8x C    21.7000  -13.3700
            25  C8x C    20.5100  -14.0700
            26  C5a C    24.1500  -13.3700
            27  N1b N    25.3400  -14.0700
            28  C1b C    26.5300  -13.3700
            29  C3b C    27.7200  -14.0700
            30  O5a O    24.1500  -11.9700
            31  N3a N    28.9100  -14.7700
            32  X   Cl   26.2500  -19.1100
            33  O0  O    22.4000  -19.1800
            34  X   Cl   26.2500  -19.1100
BOND        34
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     1   6 1
            7     5   7 1
            8     7   8 2
            9     8   9 1
            10    9  10 2
            11   10  11 1
            12   11  12 2
            13    7  12 1
            14   10  13 1
            15   13  14 1
            16   14  15 1
            17   15  16 2
            18   16  17 1
            19   17  18 2
            20   18  19 1
            21   14  19 2
            22   18  20 1
            23   20  21 2
            24   21  22 1
            25   22  23 2
            26   23  24 1
            27   24  25 2
            28   20  25 1
            29   23  26 1
            30   26  27 1
            31   27  28 1
            32   28  29 1
            33   26  30 2
            34   29  31 3
BRACKET     1    24.3600  -20.1600   24.3600  -17.9200
            1    27.3000  -17.9200   27.3000  -20.1600
            1  2
  ORIGINAL  1   32
  REPEAT    1   34
///
